Facebook Tracking Image

National Comprehensive Cancer Network

Members Only
NCCN Oncology Research Program (ORP)
NCCN Taiho Decitabine and Cedazuridine Research Grant Opportunity: Submit by Tuesday, January 19, 2021
Study Proposal Submission-NCCN iEnvision
ORP Recent News
ORP Scientific Publications
ORP for Industry
ORP Investigator Steering Committee
ORP Testimonials
Clinical Trials at NCCN Member Institutions
Find NCCN ORP Funded Clinical Trials at NCCN Member Institutions
ORP Grant History
Informed Consent Language Database
Points to Consider on the Best Practices for Biorepositories, Registries and Databases
NCCN Shared Resources
ORP Disclosure Policy
NCCN Collaboration with the National Business Group on Health
NCCN Health Information Technology Licensees
NCCN Policy Priorities

NCCN Research & Business Resources

Oncology Clinical Trials Information for Industry

NCCN Oncology Research Program (ORP)

The NCCN Oncology Research Program (ORP) is a comprehensive program of research platforms and scientific advisors to foster the development of world-class therapies to treat people with cancer. The NCCN ORP's core services focus on assisting companies with drug development plans and strategies, facilitating the conduct of preclinical, translational, and clinical research at NCCN Member Institutions, and ensuring that results of funded research projects are publicly disseminated.  The NCCN ORP can also establish research collaborations between NCCN Member Institutions and industry in Phase IV, quality-of-life, cancer prevention, and outcomes research.

NCCN ORP Mission Statement

The NCCN ORP fosters innovation and knowledge discovery that improve the lives of patients with cancer.

Guiding Principles:

  1. Study both FDA-approved and investigational agents/devices, to seek novel enhanced, effective, and efficient cancer therapy.
  2. Develop new insights into cancer care delivery outcomes and quality, as well as identify solutions to barriers affecting optimal cancer management.
  3. Increase opportunities for NCCN Member Institution faculty to participate in oncologic investigation and support those who are, or will become, leaders in cancer research.
  4. Demonstrate that constructive, appropriate, and transparent collaboration between academia and industry results in valuable knowledge and improved cancer management.
  5. Ensure the dissemination of knowledge gained through the program to the medical community at large through presentations at meetings and/or publication in peer-reviewed journals.

Additional Information

NCCN ORP Drug Pipeline Review Research Services

Research Platforms & Services

  • Investigator Initiated Research Grant Model
  • Protocol Development Model
  • Quality Improvement Collaboration Model
  • Multi-Industry Collaboration Model

Research Boards & Committees

  • Scientific Advisory Boards (SABs)
  • RFP Development Teams (RFPDTs)
  • Protocol Development Teams (PDTs)
  • Scientific Review Committees (SRCs)
  • Drug Development and Pipeline Review

Research Grant Process

  • Pre-approval Process
    • Request for Proposals (RFPs)
  • Post Approval Process
    • Basic Science Research Project or Clinical Protocol Development
    • Study Initiation
    • Adverse Events
    • NCCN ORP Monitoring
    • NCCN ORP Reporting
    • Investigator Meetings
    • Publication of Study Results
    • Grant Disbursements

NCCN ORP Grant History

NCCN ORP Disclosure Policy

Contact the NCCN Oncology Research Program